会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • 2,2-BIS(HYDROXYMETHYL)CYCLOPROPYLIDENEMETHYL - PURINES AND -PYRIMIDINES AS ANTIVIRAL AGENTS
    • 2,2-BIS(羟甲基)环丙基二乙烯基 - 嘌呤和嘧啶类作为抗病毒剂
    • WO2003104440A2
    • 2003-12-18
    • PCT/US2003/007916
    • 2003-03-14
    • WAYNE STATE UNIVERSITYTHE REGENTS OF THE UNIVERSITY OF MICHIGANZEMLICKA, JiriZHOU, ShaomanDRACH,John, C.
    • ZEMLICKA, JiriZHOU, ShaomanDRACH,John, C.
    • C12N
    • C07D239/36C07D239/54C07D473/18C07D473/30C07D473/34C07D473/40
    • Compounds which are active against viruses have the following formulas: Formula (I), Formula (II), wherein B is a purine or pyrimidine heterocyclic ring or base. In a preferred embodiment, the purine include 6-aminopurine (adenine), 6-hydroxypurine (hypoxanthine), 2-amino-6-hydroxypurine (guanine), 2,6-diamino-purine, 2-amino-6-azidopurine, 2-amino-6-halo substituted purines such as 2-amino­6-chloropurine, 2-amino-6-fluoropurine, 2-amino-6-alkoxypurines such as 2-amino-6-methoxypurine, 2-amino-6-cyclopropylaminopurine, 2-amino-­6-alkylamino or 2-amino-6-dialkylamino substituted purines, 2-amino-­6-thiopurine, 2-amino-6-alkylthio substituted purines, 3-deazapurines, 7-deazapurines and 8-azapurines. The pyrimidine incorporates cytosine, uracil and thymine, 5-halo substituted cytosines and uracils, 5-alkyl substituted cytosines and uracils including derivatives with a saturated or unsaturated alkyl group and 6-azapyrimidines.
    • 对病毒有活性的化合物具有下式:式(I),式(II),其中B是嘌呤或嘧啶杂环或碱基。 在优选的实施方案中,嘌呤包括6-氨基嘌呤(腺嘌呤),6-羟基嘌呤(次黄嘌呤),2-氨基-6-羟基嘌呤(鸟嘌呤),2,6-二氨基嘌呤,2-氨基-6-叠氮基嘌呤,2 2-氨基-6-氯嘌呤,2-氨基-6-氟嘌呤,2-氨基-6-氟代嘌呤,2-氨基-6-甲氧基嘌呤,2-氨基-6-环丙基氨基嘌呤,2 2-氨基-6-烷基氨基或2-氨基-6-二烷基氨基取代的嘌呤,2-氨基-6-硫嘌呤,2-氨基-6-烷硫基取代的嘌呤,3-脱氮嘌呤,7-脱氮嘌呤和8-氮杂嘌呤。 嘧啶含有胞嘧啶,尿嘧啶和胸腺嘧啶,5-卤素取代的胞嘧啶和尿嘧啶,5-烷基取代的胞嘧啶和尿嘧啶,包括具有饱和或不饱和烷基的衍生物和6-氮杂嘧啶。
    • 5. 发明申请
    • NOVEL 2-AMINO-9-[(2-HYDROXYMETHYL) CYCLOPROPYLIDENEMETHYL] PURINES AS ANTIVIRAL AGENTS
    • 新型2-氨基-9- [(2-羟甲基)环丙基咪唑]作为抗病毒剂
    • WO2004006867A2
    • 2004-01-22
    • PCT/US2003/007909
    • 2003-03-13
    • WAYNE STATE UNIVERSITYTHE REGENTS OF THE UNIVERSITY OF MICHIGANZEMLICKA, JiriDRACH, John, C.
    • ZEMLICKA, JiriDRACH, John, C.
    • A61K
    • C07D473/00C07F9/65616
    • Compounds which are active against viruses have the Formulas (1) and (2), wherein B is 2-aminopurine-9-yl, which may be unsubstituted or substituted in the 6 position with NHR 1 , OR 2 , or SR 3 ; R l is selected from the group consisting of alkyl, alkenyl, alkynyl, and C 4-18 cycloalkyl, any of which may be optionally substituted with one or more members of the group consisting of hydroxy, halo, amino, acyl, cycloalkyl, heterocyclyl and aryl; R 2 is selected from the group consisting of C 2-18 alkyl, alkenyl, alkynyl, and cycloalkyl, any of which may be branched or unbranched and optionally substituted with one or more members of the group consisting of hydroxy, halo, amino, acyl, cycloalkyl, heterocyclyl, and aryl; and R 3 is selected from the group consisting of alkyl, alkenyl, alkynyl, and cycloalkyl, any of which may be branched or unbranched and optionally substituted with one or more members of the group consisting of hydroxy, halo, amino, acyl, cycloalkyl, heterocyclyl and aryl.
    • 对病毒有活性的化合物具有式(1)和(2),其中B是2-氨基嘌呤-9-基,其可以是未取代的或在6位被NHR1,OR2或SR3取代; R 1选自烷基,烯基,炔基和C 4-18环烷基,其中任何一个可以任选地被羟基,卤素,氨基,酰基,环烷基,杂环基和芳基中的一个或多个成员取代 ; R2选自C2-18烷基,烯基,炔基和环烷基,其中任何一个可以是支链或非支链的,并且任选被一个或多个由羟基,卤素,氨基,酰基,环烷基 ,杂环基和芳基; 并且R 3选自烷基,烯基,炔基和环烷基,其中任何一个可以是支链或非支链的,并且任选被一个或多个由羟基,卤素,氨基,酰基,环烷基,杂环基 和芳基。